These studies and five others were included in the meta-analyses by Naderi and Rahimzadeh [17], which confirmed the presence of higher serum KL-6 in patients with severe COVID-19 compared with mild-to-moderate COVID-19, as well as with healthy controls. This evidence concerns the gene MUC1 and COVID-19.